Merck Serono, a division of German's Merck KGaA, has announced a new five-year clinical development agreement with Quintiles. This strategic collaboration is the first-of-its-kind between a ...

with the German firm’s Merck Serono division licensing various technologies used to engineer T-cells to target cancers, including its RheoSwitch platform for controlling gene expression and ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver ...

Visitors can capture their photos with the Red Card at the stand to contribute to a powerful visual Mosaic symbol of ...

Ozanimod▼ is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (RRMS) with active ...

In Europe and Canada, where the drug is marketed by Geneva-based Merck Serono and Serono of Mississauga, Ontario, respectively, regulators have taken Raptiva off the market, stating that the ...